Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting
Go back to Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.31 -0.02 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.33 | 52 Week High | $4.76 | |||
| Open | $2.36 | 52 Week Low | $1.46 | |||
| Day High | $2.39 | P/E | N/A | |||
| Day Low | $2.30 | EPS | $-1.91 | |||
| Volume | 742,390 | |||||
